ClinicalTrials.Veeva

Menu

taVNS for Letter Learning in Dyslexia

University of Florida logo

University of Florida

Status

Suspended

Conditions

Dyslexia

Treatments

Device: active taVNS
Device: sham taVNS

Study type

Interventional

Funder types

Other

Identifiers

NCT06127550
IRB202301883

Details and patient eligibility

About

This is a pilot study to establish feasibility of transcutaneous auricular vagus nerve stimulation (taVNS) for improving letter-learning in adolescents with dyslexia. The main goals of the study are to 1) evaluate whether children in this age range will tolerate low level stimulation over the course of multiple sessions, 2) determine whether low level taVNS improves novel letter learning in dyslexia, and 3) evaluate the effect of low level taVNS on the brain's response to letters. Participants will complete fMRI before training, immediately after training, and a few weeks after training ends. Training will consist of six 30-minute lessons during which participants will learn novel letter-sound relationships while receiving either active or sham taVNS. Researchers will compare stimulation conditions to determine effect of this device on learning and neural plasticity.

Enrollment

100 estimated patients

Sex

All

Ages

10 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Normal non-verbal IQ
  • Reading scores above 90 on four single word reading measures (typical reader) OR reading scores below 90 on two or more single word reading measures (dyslexia) with or without ADHD

Exclusion criteria

  • Neurological diagnoses (e.g., autism, epilepsy, etc.)
  • Medications other than those prescribed for ADHD
  • Nonverbal IQ below 80

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Active taVNS
Experimental group
Description:
Participants will receive custom current at 5 Hz to the left auricular branch of the vagus nerve while learning new letter-sound relationships.
Treatment:
Device: active taVNS
Sham taVNS
Sham Comparator group
Description:
Participants will undergo current thresholding but device will be turned off without their knowledge during the training.
Treatment:
Device: sham taVNS

Trial contacts and locations

1

Loading...

Central trial contact

Tracy Centanni, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems